ARCH Venture Management, LLC Diversified Active

CIK: 0001274403 · Show all filings

Period: Q1 2023 (← Previous) (Next →)

Filing Date: May 15, 2023

Total Value ($000): $207,180 (100.0% shares, 0.0% debt)

Holdings (8)

— EQRX, INC. 34.0%

Value ($000) $70,491 Shares 36,335,375 Est. Cost $6.82 Unrealized —

DNLI DENALI THERAPEUTICS, INC. 28.6%

Value ($000) $59,184 Shares 2,568,749 Est. Cost $26.20 Unrealized +5.1%

ERAS ERASCA, INC. 16.1%

Value ($000) $33,277 Shares 11,055,554 Est. Cost $17.12 Unrealized -78.8%

— VERVE THERAPEUTICS, INC. 14.0%

Value ($000) $28,967 Shares 2,008,809 Est. Cost $36.87 Unrealized —

— KARUNA THERAPEUTICS, INC. 2.6%

Value ($000) $5,449 Shares 30,000 Est. Cost $131.00 Unrealized —

— SINGULAR GENOMICS SYSTEMS, INC. 2.2%

Value ($000) $4,597 Shares 3,798,926 Est. Cost $11.56 Unrealized —

NTRA NATERA, INC. 1.7%

Value ($000) $3,578 Shares 64,441 Est. Cost $47.99 Unrealized 0.0%

— UNITY BIOTECHNOLOGY, INC. 0.8%

Value ($000) $1,638 Shares 1,004,817 Est. Cost $0.40 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	EQRX, INC.	36,335,375	$70,491	34.0%	$6.82	—	COM	26886C107
DNLI	DENALI THERAPEUTICS, INC.	2,568,749	$59,184	28.6%	$26.20	+5.1%	COM	24823R105
ERAS	ERASCA, INC.	11,055,554	$33,277	16.1%	$17.12	-78.8%	COM	29479A108
—	VERVE THERAPEUTICS, INC.	2,008,809	$28,967	14.0%	$36.87	—	COM	92539P101
—	KARUNA THERAPEUTICS, INC.	30,000	$5,449	2.6%	$131.00	—	COM	48576A100
—	SINGULAR GENOMICS SYSTEMS, INC.	3,798,926	$4,597	2.2%	$11.56	—	COM	82933R100
NTRA	NATERA, INC.	64,441	$3,578	1.7%	$47.99	0.0%	COM	632307104
—	UNITY BIOTECHNOLOGY, INC.	1,004,817	$1,638	0.8%	$0.40	—	COM	91381U200